Drug intelligence / Profile preview

Xcede Hemostatic Patch

Development stage
Preclinical
Lead developer
Dynasil
Administration
Topical
01

Overview

The Xcede Hemostatic Patch is a resorbable medical device designed to control severe, traumatic bleeding in surgical settings, including general surgery, cardiovascular procedures, and liver resections. Developed by Xcede Technologies (a subsidiary of Dynasil Corporation of America), the patch utilizes a proprietary adhesive backing that combines a fibrin hemostatic with a sealant. It works by bonding to the glycoprotein layer of tissues within 30 to 60 seconds, providing a high-strength seal that is effective even under high pressure and is independent of the patient's natural coagulation status. The device is designed for rapid application, requiring less than one minute of preparation.

Brand names
Xcede Hemostatic Patch
Other names
Xcede Hemostatic Patch
02

Targets

EBOV GP (Zaire ebolavirus glycoprotein GP1,2 and soluble GP)Fibrin (Factor Ia)

Beyond the preview

Go deeper on Xcede Hemostatic Patch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xcede Hemostatic Patch.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call